We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Illinois Tool Works, Bank of New York Mellon, Ford and Capital One Financial
Read MoreHide Full Article
For Immediate Release
Chicago, IL – Jan 30, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (JNJ - Free Report) , Illinois Tool Works (ITW - Free Report) , Bank of New York Mellon (BK - Free Report) , Ford (F - Free Report) and Capital One Financial (COF - Free Report) .
Top Analyst Reports for Johnson & Johnson, Illinois Tool Works & BNY-Mellon
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 14 major stocks, including Johnson & Johnson, Illinois Tool Works and Bank of New York Mellon. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Johnson & Johnson’s shares have gained +28.5% in the last one year, almost in line with the +29% gain of the Zacks Large Cap Pharmaceuticals industry. J&J's fourth-quarter results were mixed as it beat estimates for earnings while missing the same for sales. As expected, J&J’s sales growth accelerated in the second half backed by higher sales in the Pharmaceutical segment and improving performance in Medical Devices.
Though quite a few key products in J&J’s portfolio like Remicade and Concerta are facing generic competition, the Zacks analyst thinks new products in all segments, label expansion of drugs like Imbruvica and Darzalex and contribution from recent acquisitions – mainly Actelion – can support top-line growth. Meanwhile, share buybacks and the restructuring initiative should provide bottom-line support. However, headwinds like generics competition, pricing pressure, sluggish growth in the Consumer segment and soft global market conditions remain.
Shares of Buy-rated Illinois Tool Works have outperformed the Zacks Industrial Machinery industry over the last three months, gaining +13.7% over the period versus the industry’s +11.7% gain. The Zacks analyst thinks the company is well positioned to benefit from its solid product portfolio and strengthening foothold in various end markets. Also, its strategic initiatives to improve margins and policy of rewarding shareholders handsomely will work in its favor.
In fourth-quarter 2017, earnings of $1.70 per share surpassed expectations by 4.9%. For 2018, the company anticipates earnings to be within $7.45-$7.65 per share, reflecting 40 cents growth at mid-point. Organic revenue growth is expected to be 3-4% while total revenues are projected to be roughly within the $15-$15.2 billion range. Enterprise initiatives are likely to contribute 100 basis points (bps) to operating margin growth. Also, the company is working to increase its dividend payout rate to 50% in August 2018.
BNY Mellon’s shares have underperformed the Zacks Major Regional Banks industry in the last six months (+8.9% vs. +21.8%). The company’s earnings have surpassed expectations in two of the trailing four quarters. Its fourth-quarter 2017 results benefited from improvement in net interest revenues along with provision benefits. However, rise in expenses and lower fee income acted as headwinds. Easing margin pressure (driven by gradual higher interest rates) and rising loan demand are expected to further aid revenue growth.
Also, potential lesser regulations, lower tax rates and cost-saving initiatives are likely to drive profitability. However, concentration risk arising from significant dependence on fee-based income remains a matter of concern for the company. If there are any changes in individual investment preferences, regulatory amendments or a slowdown in capital market activities, it could hurt the company’s financials.
Other noteworthy reports we are featuring today include Ford and Capital One Financial.
Zacks Top 10 Stocks for 2018
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?
Last year's 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp. and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Johnson & Johnson, Illinois Tool Works, Bank of New York Mellon, Ford and Capital One Financial
For Immediate Release
Chicago, IL – Jan 30, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (JNJ - Free Report) , Illinois Tool Works (ITW - Free Report) , Bank of New York Mellon (BK - Free Report) , Ford (F - Free Report) and Capital One Financial (COF - Free Report) .
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Johnson & Johnson, Illinois Tool Works & BNY-Mellon
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 14 major stocks, including Johnson & Johnson, Illinois Tool Works and Bank of New York Mellon. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Johnson & Johnson’s shares have gained +28.5% in the last one year, almost in line with the +29% gain of the Zacks Large Cap Pharmaceuticals industry. J&J's fourth-quarter results were mixed as it beat estimates for earnings while missing the same for sales. As expected, J&J’s sales growth accelerated in the second half backed by higher sales in the Pharmaceutical segment and improving performance in Medical Devices.
Though quite a few key products in J&J’s portfolio like Remicade and Concerta are facing generic competition, the Zacks analyst thinks new products in all segments, label expansion of drugs like Imbruvica and Darzalex and contribution from recent acquisitions – mainly Actelion – can support top-line growth. Meanwhile, share buybacks and the restructuring initiative should provide bottom-line support. However, headwinds like generics competition, pricing pressure, sluggish growth in the Consumer segment and soft global market conditions remain.
(You can read the full research report on Johnson & Johnson here >>>).
Shares of Buy-rated Illinois Tool Works have outperformed the Zacks Industrial Machinery industry over the last three months, gaining +13.7% over the period versus the industry’s +11.7% gain. The Zacks analyst thinks the company is well positioned to benefit from its solid product portfolio and strengthening foothold in various end markets. Also, its strategic initiatives to improve margins and policy of rewarding shareholders handsomely will work in its favor.
In fourth-quarter 2017, earnings of $1.70 per share surpassed expectations by 4.9%. For 2018, the company anticipates earnings to be within $7.45-$7.65 per share, reflecting 40 cents growth at mid-point. Organic revenue growth is expected to be 3-4% while total revenues are projected to be roughly within the $15-$15.2 billion range. Enterprise initiatives are likely to contribute 100 basis points (bps) to operating margin growth. Also, the company is working to increase its dividend payout rate to 50% in August 2018.
(You can read the full research report on Illinois Tool Works here >>>).
BNY Mellon’s shares have underperformed the Zacks Major Regional Banks industry in the last six months (+8.9% vs. +21.8%). The company’s earnings have surpassed expectations in two of the trailing four quarters. Its fourth-quarter 2017 results benefited from improvement in net interest revenues along with provision benefits. However, rise in expenses and lower fee income acted as headwinds. Easing margin pressure (driven by gradual higher interest rates) and rising loan demand are expected to further aid revenue growth.
Also, potential lesser regulations, lower tax rates and cost-saving initiatives are likely to drive profitability. However, concentration risk arising from significant dependence on fee-based income remains a matter of concern for the company. If there are any changes in individual investment preferences, regulatory amendments or a slowdown in capital market activities, it could hurt the company’s financials.
(You can read the full research report on BNY Mellon here >>>).
Other noteworthy reports we are featuring today include Ford and Capital One Financial.
Zacks Top 10 Stocks for 2018
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?
Last year's 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp. and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2018 today >>
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.